how many people gain weight back after semaglutide Regain Semaglutide: Prevention & Sustainability Weight Regain After Ozempic: Preventing
Description
Injection site nodules or persistent induration lasting beyond one week may indicate lipohypertrophy, sterile abscess formation, or rarely, localized inflammatory reactions

GLP-1 receptor agonists are being used by millions of patients worldwide, so it is important to continue evaluating potential systemic and ocular effects

10.1007/s00210-024-03402-2 Sutherland EW, Rall TW (1958) Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles
Tirzepatide (GLP-Squared Injection option at PlexusDx) activates both GLP-1 and GIP receptors, targeting two satiety pathways instead of one

And thats a concern to us

The bottom line GLP-1 drugs are not a replacement for insulin, and they are not officially approved for T1D (outside of the new 2026 ADA recommendation for T1D with obesity)
